| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |